Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of diluted epinephrine during gastric endoscopic submucosal dissection: an international randomized controlled trial.

Gastrointestinal endoscopy·2026
Same author

Evaluation of a new method, "non-injection resection using bipolar soft coagulation mode (NIRBS)", for colonic adenomatous lesions.

Clinical endoscopy·2023
Same author

Enhanced neuron-glia network in the submucosa and increased neuron outgrowth into the mucosa are associated with distinctive expressions of neuronal factors in the colon of rat IBS model.

Neurogastroenterology and motility·2023
Same author

Platypnea-Orthodeoxia: An Effective Diagnostic Tool for Hepatopulmonary Syndrome With Chronic Obstructive Pulmonary Disease.

Cureus·2023
Same author

Tryptase activates enteric glial cells followed by affecting neuronal properties possibly via the stimuli-associated mediators.

Journal of pharmacological sciences·2023
Same author

Smoking and drinking habits relating to development of ulcerative colitis in Japanese: A multicenter case-control study.

JGH open : an open access journal of gastroenterology and hepatology·2023

Related Experiment Videos

Gastrointestinal bleeding after percutaneous coronary intervention.

Tetsuya Tanigawa1, Toshio Watanabe, Yuji Nadatani

  • 1Department of Gastroenterology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka City, Japan. ttanigawa@med.osaka-cu.ac.jp

Digestion
|January 27, 2011
PubMed
Summary
This summary is machine-generated.

Dual antiplatelet therapy after percutaneous coronary intervention (PCI) increases gastrointestinal (GI) bleeding risk by approximately 2%. Identifying and mitigating risk factors is crucial for patient outcomes following PCI procedures.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Gastroenterology
  • Pharmacology

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Dual antiplatelet therapy (DAPT) with aspirin and thienopyridine is standard post-PCI care.
  • Gastrointestinal (GI) bleeding is a serious complication of DAPT.

Purpose of the Study:

  • To review published studies on GI bleeding in patients undergoing PCI.
  • To identify the prevalence, risk factors, and consequences of GI bleeding after PCI.
  • To evaluate current prophylactic strategies and the need for further research.

Main Methods:

  • Systematic review of published literature on GI bleeding post-PCI.
  • Analysis of prevalence, associated risk factors, and clinical outcomes.
  • Assessment of proposed prophylactic measures.

Main Results:

  • GI bleeding occurs in approximately 2% of patients on DAPT post-PCI.
  • Major risk factors include advanced age, history of peptic ulcers, NSAID/anticoagulant use, and stress.
  • GI bleeding increases morbidity, mortality, hospitalization duration, and costs.

Conclusions:

  • DAPT following PCI significantly increases GI bleeding risk.
  • Several risk factors are identified, necessitating careful patient selection and monitoring.
  • Further randomized controlled trials are needed to establish optimal prophylactic strategies against GI bleeding post-PCI.